Cedric-Hermans-co-opted-2024

Cedric Hermans co-opted to WFH Board of Directors

The World Federation of Hemophilia (WFH) is very pleased to announce that Cedric Hermans has been co-opted to its Board of Directors as a Medical Member from April 25, 2024, to the next Annual Meeting of the General Assembly at the WFH 2026 World Congress in Kuala Lumpur, Malaysia.

Also available in: Français Español

Cedric Hermans, MD, PhD, was previously a WFH board member from 2017 until the WFH 2024 World Congress in Madrid, Spain. His co-option is a testament to his invaluable contributions to the WFH.

Hermans heads the Division of Haematology, the Hemostasis and Thrombosis Unit as well as the Hemophilia Centre of the Saint-Luc University Hospital in Brussels, Belgium. He was appointed Full Professor at the Medical School of the Catholic University of Louvain in 2012 and Vice-Dean in 2015.

He has (co)-authored more than 360 original articles in international journals and is a member of several scientific societies and international advisory boards and collaborative research projects. He was president of EAHAD and is currently Editor-in-Chief of Haemophilia, the official journal of the WFH.

Cedric Hermans’ invaluable experience will continue to be a great asset to the WFH as a Medical Member. Please join us in welcoming him to the WFH Board of Directors.

We’ve accomplished a lot this year, we need your help to continue strong.

Would you like to read more about similar articles?

Disclaimer

The information on the WFH website is provided for general information purposes only. The WFH does not engage in the practice of medicine and under no circumstances recommends particular treatment for specific individuals. For diagnosis or consultation on a specific medical problem, the WFH recommends that you contact your physician or local treatment centre. Before administering any products, the WFH urges patients to check dosages with a physician or hemophilia centre staff, and to consult the pharmaceutical company’s printed instructions.

While every effort has been made to ensure the accuracy of the information on this site, the WFH does not guarantee the information is accurate, and is not responsible in any way whatsoever for damages arising out of the use of this website or any of the information contained herein.

Messages posted to WFH discussion forums, Facebook, Twitter, and other social media platforms do not represent the opinions of the World Federation of Hemophilia, its staff, or Board of Directors. The author of a message is solely responsibility for its content. Information posted on WFH social networks and platforms should never be a substitute for individualized professional medical advice, even when the author has medical qualifications or is considered an authority. Information posted to a discussion group should not be used to diagnose or treat a specific health problem without consulting a qualified healthcare professional. The WFH recommends that you contact your physician or local treatment centre if you have any individual questions or concerns.

References and links to other websites or references to other organizations, products, services, or publications do not constitute endorsement or approval by the WFH. The WFH is not responsible and assumes no liability for the content of any linked websites.

Fraud Alert

Unauthorized solicitations – Warning

The WFH has been made aware of various correspondences—circulated via e-mail and telephone—coming from individuals impersonating WFH staff or falsely stating that they are associated with the WFH. These correspondences, which may seek to obtain money using the name of someone affiliated with the WFH, are fraudulent and come from outside of our organization.

If you receive a suspicious solicitation, exercise extreme caution. In the case of an email, look at the email address to see if it looks suspicious (for example, all WFH emails come from @wfh.org).

We are asking you to remain vigilant, and if you have any doubts about the correspondence, please forward the email to the WFH at [email protected] or call +1 514-875-7944.